Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354146
Status:
COMPLETED
Last Update Posted:
2011-02-01
First Post:
2006-07-18
Brief Title:
A Phase 2 Study of Farnesyl Transferase Inhibitor R115777 Tipifarnib in Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-18
First Submit QC Date:
July 18 2006
Study First Post Date:
2006-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-01-31
Last Update Post Date:
2011-02-01
Last Update Post Date Type:
ESTIMATED